Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
next big runner for sure. $PASO
PASO is total game changer.
Looking forward to what they have coming for us
PASO has the look of next OTC runner with their The assets, the NET income, the PR’s clearly show that PASO has the opportunity to have a SHMP type RUN all on FACTUAL & REAL things, not on speculation or HOPE
if one traces the timeline of PASO they is MUCH healthier financially
PASO entry into a Joint Venture with NYIE Physician Group. This Joint Venture is trending 29.9% growth in Topline income for 6 months
More significant news incoming PASO has increased year over year quarterly revenue 62%
This company is way undervalued in my opinion
The parcels have a combined area of 43,480 square feet or 1.0 acre. The transaction is expected to be complete in 30 days.
The agreement includes the aforementioned 4200 square foot facility and an adjoining lot that be utilized for future expansion.
PASO has entered into an agreement to purchase The Castro Medical Building located at 1056 West Jericho Turnpike, Smithtown, NY.
$PASO closed up 15.34 percent on Friday, August 23, 2019, on 2.95 times normal volume.
$PASO closed up 15.34 percent on Friday, August 23, 2019, on 2.95 times normal volume.
Looking real good
This play is on my radar next week
Strong close here
This building houses multiple medical specialists and will make a nice addition to company.
Purchasing a medical building in New York as part of the company's ongoing expansion plans.
PASHealth are bridging the gap and delivering solutions by Streamlining the Healthcare Management field.
The ratio of Administrators to Doctors in the Healthcare Networks throughout The United States is over 3000%.
As Healthcare costs increase year over year, the cost of Administration and Management, as shown in this chart, increases at a much greater rate.
could be a solid runner in the coming months.
This company is way undervalued in my opinion
$PASO. Looking forward to next week
ARSN become an agent of radical change in what has traditionally been a slowly evolving healthcare environment.
Just a matter time... Will become a nice runner.
multi bagger potential from here.
Looking forward to the future of this company
this healthcare one is getting ready to scoot.
talk about accumulation. You can see where this is going.
what a diamond in the rough. Load
Currently their working hard to get current
expecting this to run today
Get ready world. This will go fast
$PASO Monster in the making.
Looking for a breakout run today
Dr. Donald Chiappetta, COO, stated, “Our focus on maximizing efficiencies throughout our enterprise while executing on our growth strategy has succeeded beyond our expectations. As an organization we will continue to focus on maintaining our productivity and profitability. We are well positioned to continue into our next phase of expansion which we plan to notify our shareholders of in the coming weeks. Management would like to thank our team of professionals that have come together to make these achievements possible.”
it has increased its year over year quarterly net revenue 62% from $195,443.05 to $313,840.84.
Hestia Investments (www.hestiainsight.com) provides strategic consulting and capital market advisory services for selective micro, small and medium sized companies in the healthcare, biotech and fintech sectors. Mr. Lee is a veteran investment banker and entrepreneur with more than 30-years’ experience managing public and private companies both in U.S. and Greater China.
The Company will update its shareholders over the coming weeks with additional information.